Cargando…
A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324416/ https://www.ncbi.nlm.nih.gov/pubmed/32556680 http://dx.doi.org/10.1007/s00432-020-03286-8 |
_version_ | 1783551937855094784 |
---|---|
author | Veen, Kevin M. de Angst, Isabel B. Mokhles, Mostafa M. Westgeest, Hans M. Kuppen, Malou Groot, Carin A. Uyl-de Gerritsen, Winald R. Kil, Paul J. M. Takkenberg, Johanna J. M. |
author_facet | Veen, Kevin M. de Angst, Isabel B. Mokhles, Mostafa M. Westgeest, Hans M. Kuppen, Malou Groot, Carin A. Uyl-de Gerritsen, Winald R. Kil, Paul J. M. Takkenberg, Johanna J. M. |
author_sort | Veen, Kevin M. |
collection | PubMed |
description | PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-resistant prostate cancer was used to guide clinicians through the steps of developing a prediction model. The model of choice was the Cox proportional hazard model. RESULTS: Using the exemplary dataset several essential steps in prediction modelling are discussed including: coding of predictors, missing values, interaction, model specification and performance. An advanced method for appropriate selection of main effects, e.g. Least Absolute Shrinkage and Selection Operator (LASSO) regression, is described. Furthermore, the assumptions of Cox proportional hazard model are discussed, and how to handle violations of the proportional hazard assumption using time-varying coefficients. CONCLUSION: This study provides a comprehensive detailed guide to bridge the gap between the statistician and clinician, based on a large dataset of real-world patients treated for castration-resistant prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03286-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7324416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73244162020-07-07 A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer Veen, Kevin M. de Angst, Isabel B. Mokhles, Mostafa M. Westgeest, Hans M. Kuppen, Malou Groot, Carin A. Uyl-de Gerritsen, Winald R. Kil, Paul J. M. Takkenberg, Johanna J. M. J Cancer Res Clin Oncol Review – Clinical Oncology PURPOSE: With the increasing interest in treatment decision-making based on risk prediction models, it is essential for clinicians to understand the steps in developing and interpreting such models. METHODS: A retrospective registry of 20 Dutch hospitals with data on patients treated for castration-resistant prostate cancer was used to guide clinicians through the steps of developing a prediction model. The model of choice was the Cox proportional hazard model. RESULTS: Using the exemplary dataset several essential steps in prediction modelling are discussed including: coding of predictors, missing values, interaction, model specification and performance. An advanced method for appropriate selection of main effects, e.g. Least Absolute Shrinkage and Selection Operator (LASSO) regression, is described. Furthermore, the assumptions of Cox proportional hazard model are discussed, and how to handle violations of the proportional hazard assumption using time-varying coefficients. CONCLUSION: This study provides a comprehensive detailed guide to bridge the gap between the statistician and clinician, based on a large dataset of real-world patients treated for castration-resistant prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03286-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-17 2020 /pmc/articles/PMC7324416/ /pubmed/32556680 http://dx.doi.org/10.1007/s00432-020-03286-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review – Clinical Oncology Veen, Kevin M. de Angst, Isabel B. Mokhles, Mostafa M. Westgeest, Hans M. Kuppen, Malou Groot, Carin A. Uyl-de Gerritsen, Winald R. Kil, Paul J. M. Takkenberg, Johanna J. M. A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title | A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title_full | A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title_fullStr | A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title_full_unstemmed | A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title_short | A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
title_sort | clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer |
topic | Review – Clinical Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324416/ https://www.ncbi.nlm.nih.gov/pubmed/32556680 http://dx.doi.org/10.1007/s00432-020-03286-8 |
work_keys_str_mv | AT veenkevinm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT deangstisabelb acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT mokhlesmostafam acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT westgeesthansm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT kuppenmalou acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT grootcarinauylde acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT gerritsenwinaldr acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT kilpauljm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT takkenbergjohannajm acliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT veenkevinm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT deangstisabelb cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT mokhlesmostafam cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT westgeesthansm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT kuppenmalou cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT grootcarinauylde cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT gerritsenwinaldr cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT kilpauljm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer AT takkenbergjohannajm cliniciansguidefordevelopingapredictionmodelacasestudyusingrealworlddataofpatientswithcastrationresistantprostatecancer |